Compounds > busulfan
Page last updated: 2024-10-24

busulfan and Brain Stem Neoplasms

busulfan has been researched along with Brain Stem Neoplasms in 1 studies

Brain Stem Neoplasms: Benign and malignant intra-axial tumors of the MESENCEPHALON; PONS; or MEDULLA OBLONGATA of the BRAIN STEM. Primary and metastatic neoplasms may occur in this location. Clinical features include ATAXIA, cranial neuropathies (see CRANIAL NERVE DISEASES), NAUSEA, hemiparesis (see HEMIPLEGIA), and quadriparesis. Primary brain stem neoplasms are more frequent in children. Histologic subtypes include GLIOMA; HEMANGIOBLASTOMA; GANGLIOGLIOMA; and EPENDYMOMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouffet, E1
Raquin, M1
Doz, F1
Gentet, JC1
Rodary, C1
Demeocq, F1
Chastagner, P1
Lutz, P1
Hartmann, O1
Kalifa, C1

Other Studies

1 other study available for busulfan and Brain Stem Neoplasms

ArticleYear
Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas.
    Cancer, 2000, Feb-01, Volume: 88, Issue:3

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biops

2000